Experts at the 2026 AAD Annual Meeting explained that teledermatology helps dermatologists manage their workload and expand patient access beyond traditional in-person care. Elizabeth Jones, MD, FAAD, ...

Maria Hordinsky, MD, discusses the promise of Janus kinase (JAK) inhibitors in treating alopecia areata in the long term.

Tyrosine kinase inhibitors (TKIs) lead to similar outcomes across racial and ethnic groups when used to treat acute myeloid ...

James Song, MD, discusses the direction teledermatology is heading and how more inclusive clinical trials can improve ...

Between 4.9 million and 10.1 million people enrolled in Medicaid expansion are projected to lose coverage in 2028 under the ...

A new report suggests patients with obesity and chronic spontaneous urticaria (CSU) tend to be older when diagnosed with the latter condition, and are also less likely to respond to omalizumab (Xolair ...

Mobile screening for kidney disease may be a valuable tool in improving population health and identifying at-risk patients, ...

Linda Stein Gold, MD, shares recent findings from the pooled phase 3 analysis of the ADORING 1 and ADORING 2 trials for ...

Scalp tape-strips may represent a new, minimally invasive means by which to assess disease activity and treatment response in ...

Ruxolitinib cream can meaningfully improve skin repigmentation and QOL for patients with vitiligo, but its full benefit depends on improved patient education, guidance, and support for consistent, ...

A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...

A new systematic review and meta-analysis suggests that nerandomilast (Jascayd; Boehringer Ingelheim), an oral therapy for ...